HealthCor Management’s Centene CNC Stock Holding History

HealthCor Management’s Portfolio CNC Stock Details CNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-300,970	Closed	-$23.4M	–	34
2022 Q3	$23.4M	Sell	300,970 -239,890	-44%	-$21.4M	2.93%	11
2022 Q2	$45.8M	Sell	540,860 -93,750	-15%	-$7.79M	4.6%	5
2022 Q1	$53.4M	Sell	634,610 -115,660	-15%	-$9.49M	3.56%	8
2021 Q4	$61.8M	Sell	750,270 -232,360	-24%	-$17M	3.36%	9
2021 Q3	$61.2M	Buy	+982,630	New	+$65.7M	2.64%	13
2020 Q1	–	Sell	-560,900	Closed	-$35.3M	–	49
2019 Q4	$35.3M	Buy	+560,900	New	+$30.4M	1.26%	31
2019 Q3	–	Sell	-250,000	Closed	-$13.1M	–	59
2019 Q2	$13.1M	Sell	250,000 -766,400	-75%	-$41.4M	0.51%	42
2019 Q1	$54M	Buy	+1,016,400	New	+$61.7M	2.18%	18
2018 Q3	–	Sell	-586,360	Closed	-$36.1M	–	47
2018 Q2	$36.1M	Buy	+586,360	New	+$33.8M	1.15%	31
2017 Q3	–	Sell	-865,728	Closed	-$34.6M	–	44
2017 Q2	$34.6M	Buy	+865,728	New	+$32.7M	1.25%	24
2014 Q2	–	Sell	-900,000	Closed	-$14M	–	56
2014 Q1	$14M	Buy	+900,000	New	+$13.9M	0.84%	32

Other funds holding CNC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

HealthCor Management's CNC Position: Q4 2022 in Review

HealthCor Management sold out of Centene (CNC) in Q4 2022, closing a stake of 300,970 shares — an estimated $23.4M sold.

HealthCor Management first reported a position in CNC in Q1 2014 and held it in 11 quarters. The position peaked at $61.8M in Q4 2021. 879 funds tracked by Wall St. Rank hold CNC as of Q4 2022.

HealthCor Management reported no remaining Centene position as of Q4 2022 after selling out during the quarter.
HealthCor Management sold 300,970 Centene shares in Q4 2022, an estimated $23.4M.
HealthCor Management first reported a position in Centene in Q1 2014 and held it in 11 quarters.
HealthCor Management's Centene position peaked at $61.8M in Q4 2021.
879 funds tracked by Wall St. Rank held Centene as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.